Philip Morris International is a leading global organization in the tobacco industry, primarily known for manufacturing and distributing a variety of smokeable products, including cigarettes and heated tobacco devices. The company is committed to transforming its business by investing in reduced-risk products, promoting alternatives to traditional smoking, such as e-cigarettes and heated tobacco products that aim to deliver nicotine without the harmful effects associated with combustion. With a strong emphasis on innovation and sustainability, Philip Morris International is actively shifting its focus towards a smoke-free future, striving to create a healthier environment while still engaging its customer base. Read More
Philip Morris’s fourth quarter results were driven by strong growth in its smoke-free portfolio, with management emphasizing double-digit volume gains for its IQOS, ZYN, and VIVE products across multiple regions. CEO Jacek Olczak called attention to the accelerated adoption of smoke-free alternatives, stating, “Our leading global position in smoke-free products enables us to deliver a fifth consecutive year of positive volumes.” Growth was broad-based, including notable gains in Europe, rapid expansion in new markets like Taiwan, and resilience in combustibles despite normalized industry declines and specific supply chain disruptions, particularly in Turkey.
Tobacco company Philip Morris International (NYSE:PM) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $10.36 billion. Its non-GAAP profit of $1.70 per share was in line with analysts’ consensus estimates.
As of February 6, 2026, Philip Morris International (NYSE: PM) stands at a historic crossroads. Long regarded as the quintessential "Big Tobacco" play, the company has spent the last decade aggressively cannibalizing its own legacy combustible business to lead a global "smoke-free" revolution. Today, the results of this gamble are no longer speculative; they are [...]
Tobacco company Philip Morris International (NYSE:PM) met Wall Streets revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $10.36 billion. Its non-GAAP profit of $1.70 per share was in line with analysts’ consensus estimates.
